Over the past decade, Japan's insulin dosage market has experienced fluctuating trends. From 2012 to 2015, the market size in value saw a steep decline, reflected in year-on-year reductions from -11.9% to -15.43%. However, the contraction slowed between 2016 and 2017, with almost flat growth of 0.44% year-on-year in these years. A significant drop occurred again in 2018 and 2019, but 2020 and 2021 witnessed slight positive growth.
Key trends over the last two years indicate volatility, with a 6.15% increase in 2020 followed by a marginal 0.79% in 2021 and a dramatic -13.93% decrease in 2022. The CAGR over the last five years highlights an average annual decline of -4.89%.
Future trends to watch for:
- Potential technological advancements in insulin delivery systems.
- Commitment to healthcare policies that might impact market size and value.
- Impact of an aging population on insulin demand in Japan.
How does Japan rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | |
| 6 | 6 Italy | 1,149,100,000 | 2023 | -2.49% | -2.35% | View data |
| 7 | 7 Spain | 810,390,000 | 2023 | -1.52% | -0.44% | View data |
